Global Information
회사소개 | 문의 | 비교리스트

세계의 펩티드 합성 시장 예측(-2023년) : 시약, 합성기, 크로마토그래피

Peptide Synthesis Market by Product (Reagent, Synthesizer, Chromatography), Technology (Solid Phase, Liquid Phase, and Hybrid & Recombinant), End User (Pharmaceuticals & Biotechnology, CRO), and Region - Global Forecast to 2023

리서치사 MarketsandMarkets
발행일 2018년 07월 상품 코드 664123
페이지 정보 영문 136 Pages
가격
US $ 4,950 ₩ 5,964,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,650 ₩ 8,013,000 PDF by E-mail (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,150 ₩ 9,820,000 PDF by E-mail (Corporate License) help
기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없지만, 동일 국가의 동일 사업장에 한정되며 해외지점 등은 포함되지 않습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 10,000 ₩ 12,050,000 PDF by E-mail (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 펩티드 합성 시장 예측(-2023년) : 시약, 합성기, 크로마토그래피 Peptide Synthesis Market by Product (Reagent, Synthesizer, Chromatography), Technology (Solid Phase, Liquid Phase, and Hybrid & Recombinant), End User (Pharmaceuticals & Biotechnology, CRO), and Region - Global Forecast to 2023
발행일 : 2018년 07월 페이지 정보 : 영문 136 Pages

세계의 펩티드 합성 시장은 예측기간 중 6.5%의 연평균 성장률(CAGR)로 성장하여, 2018년 3억 1,050만 달러에서 2023년에는 4억 2,640만 달러 규모로 확대될 전망입니다. 의약품 이용 확대, 연구 활동 활발화, R&D 자금 이용 가능성, 첨단 펩티드 합성기 개발 등의 요인이 시장 성장을 촉진할 전망입니다.

세계의 펩티드 합성(Peptide Synthesis) 시장에 대해 조사했으며, 시장 정의와 개요, 시장 성장에 대한 영향요인 및 시장 기회, 제품·기술·최종사용자·지역/주요 국가별 동향, 시장 규모 추정과 예측, 경쟁 상황, 주요 기업 개요 등의 정보를 전해드립니다.

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 주요 조사 결과

제5장 시장 개요

  • 서론
  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
    • 과제

제6장 펩티드 합성 시장 분석과 예측 : 제품별

  • 서론
  • 시약
  • 기기
    • 펩티드 합성기
    • 크로마토그래피 장비
    • 동결건조기

제7장 펩티드 합성 시장 분석과 예측 : 기술별

  • 서론
  • 펩티드 고체상 합성법(SPPS)
  • 펩티드 액체상 합성법(SPS)
  • 하이브리드 및 재조합 기술

제8장 펩티드 합성 시장 분석과 예측 : 최종사용자별

  • 서론
  • 의약품 및 바이오테크놀러지 기업
  • CDMO 및 CRO
  • 학술 및 연구기관

제9장 펩티드 합성 시장 분석과 예측 : 지역별

  • 서론
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 기타
  • 아시아태평양
    • 중국
    • 일본
    • 인도
    • 기타
  • 라틴아메리카
  • 중동 및 아프리카

제10장 경쟁 상황

  • 개요
  • 경쟁 시나리오
  • 성장 전략 매트릭스
    • 인수
    • 제품 투입
    • 합의, 제휴, 협력
    • 확장

제11장 기업 개요

  • GENSCRIPT BIOTECH
  • MERCK KGAA
  • AAPPTEC
  • BACHEM HOLDINGS
  • ANASPEC
  • BIOTAGE
  • CEM CORPORATION
  • GYROS PROTEIN TECHNOLOGIES
  • ADVANCED CHEMTECH
  • NEP(NEW ENGLAND PEPTIDE)

제12장 부록

KSM 18.07.25

LIST OF TABLES

  • TABLE 1: PEPTIDE SYNTHESIS MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • TABLE 2: PEPTIDE SYNTHESIS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 3: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 4: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 5: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 6: MAJOR PEPTIDE SYNTHESIZERS AVAILABLE IN THE MARKET
  • TABLE 7: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 8: PEPTIDE SYNTHESIS MARKET FOR CHROMATOGRAPHY EQUIPMENT, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 9: PEPTIDE SYNTHESIS MARKET FOR LYOPHILIZERS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 10: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 11: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY 2016-2023 (USD MILLION)
  • TABLE 12: SOLUTION-PHASE SYNTHESIS MARKET, BY COUNTRY 2016-2023 (USD MILLION)
  • TABLE 13: HYBRID AND RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 14: PEPTIDE SYNTHESIS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 15: PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 16: PEPTIDE SYNTHESIS MARKET FOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 17: PEPTIDE SYNTHESIS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 18: NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 19: NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 20: NORTH AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 21: NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 22: NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 23: US: PEPTIDE SYNTHESIS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 24: US: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 25: US: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 26: US: PEPTIDE SYNTHESIS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 27: CANADA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 28: CANADA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 29: CANADA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 30: CANADA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 31: EUROPE: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 32: EUROPE: PEPTIDE SYNTHESIS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 33: EUROPE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 34: EUROPE: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 35: EUROPE: PEPTIDE SYNTHESIS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 36: GERMANY: PEPTIDE SYNTHESIS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 37: GERMANY: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 38: GERMANY: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 39: GERMANY: PEPTIDE SYNTHESIS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 40: UK: PEPTIDE SYNTHESIS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 41: UK: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 42: UK: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 43: UK: PEPTIDE SYNTHESIS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 44: FRANCE: PEPTIDE SYNTHESIS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 45: FRANCE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 46: FRANCE: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 47: FRANCE: PEPTIDE SYNTHESIS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 48: ITALY: PEPTIDE SYNTHESIS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 49: ITALY: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 50: ITALY: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 51: ITALY: PEPTIDE SYNTHESIS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 52: SPAIN: PEPTIDE SYNTHESIS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 53: SPAIN: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 54: SPAIN: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 55: SPAIN: PEPTIDE SYNTHESIS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 56: ROE: PEPTIDE SYNTHESIS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 57: ROE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 58: ROE: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 59: ROE: PEPTIDE SYNTHESIS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 60: ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 61: ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 62: ASIA PACIFIC: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 63: ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 64: ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 65: CHINA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 66: CHINA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 67: CHINA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 68: CHINA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 69: JAPAN: PEPTIDE SYNTHESIS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 70: JAPAN: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 71: JAPAN: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 72: JAPAN: PEPTIDE SYNTHESIS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 73: INDIA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 74: INDIA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 75: INDIA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 76: INDIA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 77: ROAPAC: PEPTIDE SYNTHESIS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 78: ROAPAC: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 79: ROAPAC: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 80: ROAPAC: PEPTIDE SYNTHESIS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 81: LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 82: LATIN AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 83: LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 84: LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 85: MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 86: MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 87: MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 88: MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 89: KEY ACQUISITIONS, JANUARY 2015 - JUNE 2018
  • TABLE 90: KEY PRODUCT LAUNCHES, JANUARY 2015- JUNE 2018
  • TABLE 91: KEY AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, JANUARY 2015 - JUNE 2018
  • TABLE 92: KEY EXPANSIONS, JANUARY 2015 - JUNE 2018

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: PRIMARY SOURCES
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS(SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS(DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
  • FIGURE 5: BOTTOM-UP APPROACH
  • FIGURE 6: TOP-DOWN APPROACH
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY
  • FIGURE 8: PEPTIDE SYNTHESIS MARKET, BY PRODUCT, 2018 VS. 2023 (USD MILLION)
  • FIGURE 9: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2018 VS. 2023 (USD MILLION)
  • FIGURE 10: PEPTIDE SYNTHESIS MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
  • FIGURE 11: GEOGRAPHICAL SNAPSHOT OF THE PEPTIDE SYNTHESIS MARKET
  • FIGURE 12: INCREASING USE OF PEPTIDES IN THE PHARMACEUTICAL INDUSTRY IS DRIVING MARKET GROWTH
  • FIGURE 13: THE PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES SEGMENT COMMANDED THE LARGEST SHARE OF THE PEPTIDE SYNTHESIS MARKET IN 2017
  • FIGURE 14: THE US ACCOUNTED FOR THE LARGEST SHARE OF THE PEPTIDE SYNTHESIS MARKET IN 2017
  • FIGURE 15: APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 16: REAGENTS SEGMENT TO DOMINATE THE PEPTIDE SYNTHESIS MARKET DURING THE FORECAST PERIOD
  • FIGURE 17: SOLID-PHASE PEPTIDE SYNTHESIS TO DOMINATE THE PEPTIDE SYNTHESIS TECHNOLOGY MARKET DURING THE FORECAST PERIOD
  • FIGURE 18: PEPTIDE SYNTHESIS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • FIGURE 19: PEPTIDE SYNTHESIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 20: PEPTIDE SYNTHESIS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • FIGURE 21: NORTH AMERICA: PEPTIDE SYNTHESIS MARKET SNAPSHOT
  • FIGURE 22: EUROPE: PEPTIDE SYNTHESIS MARKET SNAPSHOT
  • FIGURE 23: ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET SNAPSHOT
  • FIGURE 24: KEY DEVELOPMENTS IN THE PEPTIDE SYNTHESIS MARKET BETWEEN JANUARY 2015 AND JUNE 2018
  • FIGURE 25: GENSCRIPT: COMPANY SNAPSHOT (2017)
  • FIGURE 26: MERCK KGAA: COMPANY SNAPSHOT (2017)
  • FIGURE 27: BACHEM HOLDINGS: COMPANY SNAPSHOT (2017)
  • FIGURE 28: KANEKA CORPORATION: COMPANY SNAPSHOT (2017)
  • FIGURE 29: BIOTAGE: COMPANY SNAPSHOT (2017)

"The peptide synthesis market is projected to grow at a CAGR of 6.5% in the next five years"

The peptide synthesis market is projected to reach USD 426.4 million by 2023 from USD 310.5 million in 2018, at a CAGR of 6.5% during the forecast period. Factors such as increasing use of peptides in pharmaceutical drugs, increase in research activities and availability of funding for R&D, and the development of advanced peptide synthesizers are expected to drive the growth of the market. However, the lack of a unified set of regulations for therapeutic peptides is expected to restrain the growth of this market during the forecast period.

"The solid-phase synthesis segment accounted for the largest market share and is expected to grow at the highest CAGR during the forecast period"

By technology, the peptide synthesis market is segmented into solid-phase, liquid -phase, and hybrid & recombinant technology. Solid-phase synthesis is associated with a number of advantages, such as ease of operation, easy purification, short production cycles, high-level automation, and synthesis capabilities of long peptides in small quantities of amino acids. Such advantages are expected to drive the adoption of solid-phase synthesis.

"The contract development and manufacturing organizations segment is projected to grow at the highest CAGR during the forecast period"

By end user, the market is segmented into pharmaceutical and biotechnology companies, contract development and manufacturing organizations, and academic and research institutes. The contract development and manufacturing organizations segment is expected to grow at the highest CAGR during the forecast period. The increasing demand for cost-effective peptide synthesis services in drug development activities and life science research is driving the growth of this segment.

"North America is projected to have the largest market share during the forecast period (2018-2023)"

North America dominated the peptide synthesis market in 2017, followed by Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the peptide synthesis market. The large share of North America in this market can be attributed to the high prevalence of chronic diseases, increasing investments in the development of structure-based drug designs, and growing research in the fields of genomics and proteomics in the region.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-45%, Tier 2-40% and Tier 3-15%
  • By Designation - C-level-41%, Director Level-30%, Others-29%
  • By Region - North America-32%, Europe-27%, Asia-Pacific-19%, Latin America-12%, Middle East & Africa- 10%

The major players in the peptide synthesis market are: GenScript Biotech Corporation (China), AAPPTec (US), Bachem (Switzerland), AnaSpec (US), Biotage (Sweden), CEM Corporation (US), Gyros Protein Technologies (Sweden), Advanced ChemTech (US), Merck KGAA (Germany) and New England Peptide (US).

Research Coverage:

The peptide synthesis market in this report is segmented by product, technology, end user, and regions. It provides detailed information regarding major factors influencing the growth market (drivers, restraints, opportunities, and industry-specific challenges). The study tracks and analyzes competitive developments (such as partnerships, agreements, collaborations, mergers & acquisitions, new product developments, geographical expansions, and R&D activities) and strategically profiles the key players and comprehensively analyzes their market shares and core competencies in the peptide synthesis market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis-market share analysis of top players, company profiles which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the peptide synthesis market; high-growth regions; and market drivers, restraints, and opportunities. The report provides the latest peptide synthesis industry statistics and industry trends, allowing buyers to identify the high growth product segment and potential customers and suppliers hence driving revenue growth and profitability.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on products offered by the top players in the global peptide synthesis market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the peptide synthesis market
  • Market Development: Comprehensive information about lucrative emerging markets - the report analyzes the markets for peptide synthesis market across regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global peptide synthesis market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global peptide synthesis market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY SOURCES
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY SOURCES
      • 2.1.2.1. Key data from primary sources
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. MARKET SHARE ESTIMATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. PEPTIDE SYNTHESIS: MARKET OVERVIEW
  • 4.2. EUROPE: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY & END USER (2017)
  • 4.3. PEPTIDE SYNTHESIS MARKET: GEOGRAPHIC SNAPSHOT
  • 4.4. PEPTIDE SYNTHESIS: GEOGRAPHIC MIX

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increasing use of peptides in pharmaceutical drugs
      • 5.2.1.2. Increase in research activities and availability of funding for R&D
      • 5.2.1.3. Development of advanced peptide synthesizers
    • 5.2.2. RESTRAINT
      • 5.2.2.1. Lack of a unified set of regulations for therapeutic peptides
    • 5.2.3. OPPORTUNITIE
      • 5.2.3.1. Emerging markets in the Asia Pacific region
    • 5.2.4. CHALLENGE
      • 5.2.4.1. Issues associated with the route of administration of peptide drugs

6. PEPTIDE SYNTHESIS MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. REAGENTS
  • 6.3. EQUIPMENT
    • 6.3.1. PEPTIDE SYNTHESIZERS
    • 6.3.2. CHROMATOGRAPHY EQUIPMENT
    • 6.3.3. LYOPHILIZERS

7. PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY

  • 7.1. INTRODUCTION
  • 7.2. SOLID-PHASE PEPTIDE SYNTHESIS (SPPS)
  • 7.3. SOLUTION-PHASE SYNTHESIS (SPS)
  • 7.4. HYBRID AND RECOMBINANT TECHNOLOGY

8. PEPTIDE SYNTHESIS MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
  • 8.3. CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION/ CONTRACT RESEARCH ORGANIZATION
  • 8.4. ACADEMIC AND RESEARCH INSTITUTES

9. PEPTIDE SYNTHESIS MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. US
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. UK
    • 9.3.3. FRANCE
    • 9.3.4. ITALY
    • 9.3.5. SPAIN
    • 9.3.6. REST OF EUROPE
  • 9.4. ASIA PACIFIC
    • 9.4.1. CHINA
    • 9.4.2. JAPAN
    • 9.4.3. INDIA
    • 9.4.4. REST OF ASIA PACIFIC
  • 9.5. LATIN AMERICA
  • 9.6. MIDDLE EAST AND AFRICA

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. COMPETITIVE SCENARIO
  • 10.3. GROWTH STRATEGY MATRIX
    • 10.3.1. ACQUISITIONS
    • 10.3.2. PRODUCT LAUNCHES
    • 10.3.3. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 10.3.4. EXPANSIONS

11. COMPANY PROFILES (Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*

  • 11.1. GENSCRIPT BIOTECH
  • 11.2. MERCK KGAA
  • 11.3. AAPPTEC
  • 11.4. BACHEM HOLDINGS
  • 11.5. ANASPEC (A SUBSIDIARY OF KANEKA EUROGENTEC S.A.)
  • 11.6. BIOTAGE
  • 11.7. CEM CORPORATION
  • 11.8. GYROS PROTEIN TECHNOLOGIES
  • 11.9. ADVANCED CHEMTECH
  • 11.10. NEP (NEW ENGLAND PEPTIDE)

*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. AVAILABLE CUSTOMIZATIONS
  • 12.5. RELATED REPORTS
  • 12.6. AUTHOR DETAILS
Back to Top
전화 문의
F A Q